Wordt geladen...
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model
OBJECTIVES: In 2002, the UK's National Institute for Health and Care Excellence concluded that the multiple sclerosis (MS) disease modifying therapies; interferon-β and glatiramer acetate, were not cost effective over the short term but recognised that reducing disability over the longer term m...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3902459/ https://ncbi.nlm.nih.gov/pubmed/24441054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2013-004073 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|